Cumulative 3.46 Million First Vaccine Doses Administered... 858 Suspected Adverse Reaction Reports Increase (Update)

New COVID-19 Cases Back to 500s

[Image source=Yonhap News]

[Asia Economy Reporter Kim Ji-hee] The number of new COVID-19 cases in South Korea has risen back to the 500s.

The Central Disease Control Headquarters (CDCH) announced that as of midnight on the 4th, there were 541 new confirmed COVID-19 cases, bringing the total to 124,269. Of these, 514 were locally transmitted cases, and 27 were imported cases. On the same day, the number of suspected cases tested was 41,829, and the number of tests conducted at temporary screening centers in the Seoul metropolitan area was 34,026, exceeding 70,000 in total. At the temporary screening centers in the metropolitan area, 52 confirmed cases were identified.

By region, Seoul in the metropolitan area reported 182 new cases. This was followed by Gyeonggi with 117 cases and Incheon with 12 cases, showing a large number of cases in the metropolitan area. In non-metropolitan areas, cases were reported across all regions, including 35 in Gyeongnam, 29 in Ulsan, 22 in Gangwon, 18 each in Chungnam and Gyeongbuk, 16 in Busan, 13 in Daejeon, 12 in Jeonbuk, 9 in Jeonnam, 8 in Jeju, 5 each in Chungbuk and Sejong, and 4 in Gwangju.

The cumulative number of COVID-19 deaths increased by 6 from the previous day, reaching 1,840. The number of critically ill patients decreased by 2 to 162. An additional 772 patients were declared recovered and released from isolation, bringing the total to 114,128.

Meanwhile, the COVID-19 Vaccination Response Promotion Team reported that as of midnight, 66,920 people received their first dose, bringing the total number of first-dose recipients to 3,466,908. Among them, 1,863,973 received the AstraZeneca vaccine, and 1,602,935 received the Pfizer vaccine. An additional 30,538 people received their second dose, bringing the total to 267,032.

The number of suspected adverse reactions reported after COVID-19 vaccination surged by 858 cases from the previous day, reaching a cumulative total of 17,485. Newly reported adverse reactions included 5 suspected anaphylaxis cases, 3 suspected severe cases, and 3 deaths. The remainder were mild symptoms such as muscle pain and headaches.

This content was produced with the assistance of AI translation services.